H Bonkhoff

Summary

Country: Germany

Publications

  1. ncbi request reprint [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype]
    H Bonkhoff
    Institut für Pathologie Bonn Duisdorf
    Urologe A 43:836-42. 2004
  2. ncbi request reprint [Implications of estrogens and their receptors for the development and progression of prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:461-8. 2005
  3. ncbi request reprint [Gleason grading: diagnostic criteria and clinical implications]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:422-32. 2005
  4. ncbi request reprint [Prognostic factors in prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:433-43. 2005
  5. ncbi request reprint [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:405-21. 2005
  6. ncbi request reprint [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:453-60. 2005
  7. ncbi request reprint Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach
    A M Luebke
    Department of Urology, University of Hamburg, Martinistrasse 52, 22081 Hamburg, Germany
    Virchows Arch 446:338-41. 2005
  8. ncbi request reprint [New insights into the role of estogens and their receptors in prostate cancer]
    H Bonkhoff
    Gemeinschaftspraxis für Pathologie, Frankfurt M
    Urologe A 42:1594-601. 2003
  9. ncbi request reprint [Solid-pseudopapillary tumor of the pancreas in a 9-year-old girl]
    S Meyer
    Klinik fur Kinder und Jugendmedizin, Homburg
    Klin Padiatr 214:316-8. 2002
  10. ncbi request reprint Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer
    U Wissenbach
    Institut fur Pharmakologie und Toxikologie, Institut für Humangnetik, und Institut für Pathologie der Universität des Saarlandes, D 66421 Homburg, Germany
    J Biol Chem 276:19461-8. 2001

Collaborators

Detail Information

Publications12

  1. ncbi request reprint [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype]
    H Bonkhoff
    Institut für Pathologie Bonn Duisdorf
    Urologe A 43:836-42. 2004
    ..Looking for NE differentiation is recommended in the pathological and clinical evaluation of prostate cancer patients for whom radiation and androgen deprivation are therapeutic options...
  2. ncbi request reprint [Implications of estrogens and their receptors for the development and progression of prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:461-8. 2005
    ..These data provide a rational for clinical trials to study the efficiency of antiestrogens in the medical treatment of advanced prostate cancer...
  3. ncbi request reprint [Gleason grading: diagnostic criteria and clinical implications]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:422-32. 2005
    ..Reporting the proportion of Gleason grades 4 and 5 in needle biopsies may be critical in terms of treatment decisions. The present review deals with diagnostic criteria of the Gleason grades and its clinical implications...
  4. ncbi request reprint [Prognostic factors in prostate cancer]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:433-43. 2005
    ..This review discusses the methods of sampling and reporting in prostate pathology with an emphasis on well established and new prognostic factors...
  5. ncbi request reprint [Differential diagnosis of prostate cancer: impact of pattern analysis and immunohistochemistry]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:405-21. 2005
    ..Finally, a selected panel of markers is useful to classify prostatic stromal lesions. In each case, immunohistochemical findings should be interpreted in context with the various patterns on routine microscopy...
  6. ncbi request reprint [Neuroendocrine differentiation in prostate cancer: an unrecognized and therapy resistant phenotype]
    H Bonkhoff
    Praxis für Pathologie, Berlin
    Pathologe 26:453-60. 2005
    ..Pathological and clinical detection of NE features is recommended for all prostate cancer patients for whom radiation therapy and androgen deprivation is being considered...
  7. ncbi request reprint Simultaneous tumour-like, atypical basal cell hyperplasia and acinar adenocarcinoma of the prostate: a comparative morphological and genetic approach
    A M Luebke
    Department of Urology, University of Hamburg, Martinistrasse 52, 22081 Hamburg, Germany
    Virchows Arch 446:338-41. 2005
    ..The pathological findings favoured the diagnosis of an atypical basal cell hyperplasia...
  8. ncbi request reprint [New insights into the role of estogens and their receptors in prostate cancer]
    H Bonkhoff
    Gemeinschaftspraxis für Pathologie, Frankfurt M
    Urologe A 42:1594-601. 2003
    ..These data provide a rationale for clinical trials to study the efficiency of antiestrogens in the medical treatment of advanced prostate cancer...
  9. ncbi request reprint [Solid-pseudopapillary tumor of the pancreas in a 9-year-old girl]
    S Meyer
    Klinik fur Kinder und Jugendmedizin, Homburg
    Klin Padiatr 214:316-8. 2002
    ..Our case report--like a recently published work by Lange et al.--intends to underline the significance of solid-pseudopapillary tumor in the differential diagnosis of a pancreatic mass...
  10. ncbi request reprint Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer
    U Wissenbach
    Institut fur Pharmakologie und Toxikologie, Institut für Humangnetik, und Institut für Pathologie der Universität des Saarlandes, D 66421 Homburg, Germany
    J Biol Chem 276:19461-8. 2001
    ..The human CaT-L channel represents a marker for prostate cancer progression and may serve as a target for therapeutic strategies...
  11. ncbi request reprint In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions
    C Pföhler
    Department of Pathology, University of the Saarland, Homburg Saar, Germany
    Prostate 36:143-50. 1998
    ....
  12. ncbi request reprint Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas
    H Bonkhoff
    Instiute of Pathology, University of the Saarland, Homburg Saar, Germany
    Prostate 29:261-7. 1996
    ..Steroid 5 alpha-reductase is essential for the intracellular accumulation of dihydrotestosterone (DHT), which mediates androgen effects on target tissue...